4//SEC Filing
Whalen Matthew Pratt 4
Accession 0001493152-24-049507
CIK 0001904286other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:15 PM ET
Size
6.3 KB
Accession
0001493152-24-049507
Insider Transaction Report
Form 4
Whalen Matthew Pratt
Director
Transactions
- Award
Stock Options (right to buy)
2024-12-09+25,000→ 25,000 totalExercise: $1.19Exp: 2034-12-09→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.
- [F2]The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.
- [F3]25,000 stock options were issued to the Reporting Person on the Grant Date, pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.
Documents
Issuer
MIRA PHARMACEUTICALS, INC.
CIK 0001904286
Entity typeother
Related Parties
1- filerCIK 0002033867
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:15 PM ET
- Size
- 6.3 KB